Literature DB >> 20022340

Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke.

Timothy J Bernard1, Laura Z Fenton, Susan D Apkon, Richard Boada, Greta N Wilkening, C Corbett Wilkinson, Jennifer B Soep, Shelley D Miyamoto, Mark Tripputi, Jennifer Armstrong-Wells, Timothy A Benke, Marilyn J Manco-Johnson, Neil A Goldenberg.   

Abstract

OBJECTIVE: To test the hypothesis that acute elevations of biomarkers of hypercoagulability and inflammation are common in children with arterial ischemic stroke (AIS), particularly among etiologic subtypes that carry an increased risk of recurrent stroke. STUDY
DESIGN: In this prospective/retrospective institutional-based cohort study of acute childhood-onset AIS (n = 50) conducted between 2005 and 2009, D-dimer, factor VIII (FVIII) activity, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were serially evaluated at the time of clinical blood sampling. Patients were classified by stroke subtype as cardioembolic, moyamoya, non-moyamoya arteriopathy, or other.
RESULTS: Both D-dimer and CRP were frequently elevated in acute childhood-onset AIS and exhibited a decreasing trend with time. Acute D-dimer levels were significantly higher in cardioembolic AIS compared with noncardioembolic AIS (median, 2.04 microg/mL [range 0.54-4.54 microg/mL] vs 0.32 microg/mL [0.22-3.18 microg/mL]; P = .002). At an optimal threshold of > or = 0.50 microg/mL, the sensitivity and specificity of D-dimer for cardioembolic subtype were 78% and 79%, respectively.
CONCLUSIONS: Our findings identify D-dimer and CRP as candidate biomarkers for etiology and prognosis in childhood-onset AIS. Further studies should investigate the role of these and other biomarkers of hypercoagulability and inflammation in childhood-onset AIS. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20022340     DOI: 10.1016/j.jpeds.2009.10.034

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

1.  Inflammatory Biomarkers in Childhood Arterial Ischemic Stroke: Correlates of Stroke Cause and Recurrence.

Authors:  Heather J Fullerton; Gabrielle A deVeber; Nancy K Hills; Michael M Dowling; Christine K Fox; Mark T Mackay; Adam Kirton; Jerome Y Yager; Timothy J Bernard; Eldad A Hod; Max Wintermark; Mitchell S V Elkind
Journal:  Stroke       Date:  2016-08-04       Impact factor: 7.914

Review 2.  Childhood arterial ischemic stroke: a review of etiologies, antithrombotic treatments, prognostic factors, and priorities for future research.

Authors:  Courtney A Lyle; Timothy J Bernard; Neil A Goldenberg
Journal:  Semin Thromb Hemost       Date:  2011-12-20       Impact factor: 4.180

3.  Factor VIII concentration is greater in female than male patients with HIV infection.

Authors:  Alireza Abdollahi; Afsaneh Morteza; Omid Khalilzadeh; Ahmad Ahmadzadeh
Journal:  Int J Hematol       Date:  2010-12-15       Impact factor: 2.490

Review 4.  The roles of anatomic factors, thrombophilia, and antithrombotic therapies in childhood-onset arterial ischemic stroke.

Authors:  Timothy J Bernard; Marilyn J Manco-Johnson; Neil A Goldenberg
Journal:  Thromb Res       Date:  2010-10-13       Impact factor: 3.944

Review 5.  Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases.

Authors:  Kirsten B Dorschel; John E Wanebo
Journal:  Appl Clin Genet       Date:  2021-03-18

6.  Arterial Ischemic Stroke Secondary to Cardiac Disease in Neonates and Children.

Authors:  Melissa G Chung; Kristin P Guilliams; Jenny L Wilson; Lauren A Beslow; Michael M Dowling; Neil R Friedman; Sahar M A Hassanein; Rebecca Ichord; Lori C Jordan; Mark T Mackay; Mubeen F Rafay; Michael Rivkin; Marcela Torres; Dimitrios Zafeiriou; Gabrielle deVeber; Christine K Fox
Journal:  Pediatr Neurol       Date:  2019-06-27       Impact factor: 3.372

7.  Arteriopathy, D-dimer, and risk of poor neurologic outcome in childhood-onset arterial ischemic stroke.

Authors:  Neil A Goldenberg; Sarah Jenkins; Jessica Jack; Jennifer Armstrong-Wells; Laura Z Fenton; Nicholas V Stence; Joyce Oleszek; Richard Boada; Greta N Wilkening; Charles Wilkinson; Jennifer B Soep; Shelley D Miyamoto; Lalit Bajaj; Peter M Mourani; Marilyn J Manco-Johnson; Timothy J Bernard
Journal:  J Pediatr       Date:  2012-12-20       Impact factor: 4.406

8.  The institution-based prospective inception cohort study: design, implementation, and quality assurance in pediatric thrombosis and stroke research.

Authors:  Timothy J Bernard; Jennifer Armstrong-Wells; Neil A Goldenberg
Journal:  Semin Thromb Hemost       Date:  2012-12-26       Impact factor: 4.180

Review 9.  Moyamoya Biomarkers.

Authors:  Edward R Smith
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

10.  Non-invasive Urinary Biomarkers in Moyamoya Disease.

Authors:  Julie Sesen; Jessica Driscoll; Alexander Moses-Gardner; Darren B Orbach; David Zurakowski; Edward R Smith
Journal:  Front Neurol       Date:  2021-04-01       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.